VTL - Vital Therapies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development-39,34130,04639,773
Selling General and Administrative-12,78911,22012,347
Non Recurring----
Total Operating Expenses-52,13041,26652,120
Operating Income or Loss--52,130-41,266-52,120
Income from Continuing Operations
Total Other Income/Expenses Net5495229797
Earnings Before Interest and Taxes--52,130-41,266-52,120
Interest Expense----
Income Before Tax--52,078-40,969-52,023
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops--52,078-40,969-52,023
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--52,078-40,969-52,023
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--52,078-40,969-52,023